3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
13
Carcinoma, Renal Cell
10
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Transitional Cell
4
Neoplasms
3
Neoplasm Metastasis
3
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Hepatocellular
3
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Multiple Myeloma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Skin Neoplasms
1
Seminoma
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Interventions
Cyclophosphamide
6
fludarabine
4
Standard of Care
4
Practice Guidelines as Topic
3
Mycophenolic Acid
3
GSK2636771
3
venetoclax
2
trametinib
2
talquetamab
2
osimertinib
2
dabrafenib
2
X-Rays
2
Whole-Body Irradiation
2
Thiotepa
2
Tacrolimus
2
Specimen Handling
2
Mesna
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
Biopsy
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
thymoglobulin
1
sapanisertib
1
ruxolitinib
1
relatlimab
1
plerixafor
1
pertuzumab
1
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Ipilimumab
×
30 days
×
Clear all
No trials found.